| Line item | 2025-07-31 FY | 2024-07-31 FY | 2023-07-31 FY | 2022-07-31 FY | 2021-07-31 FY |
|---|---|---|---|---|---|
| Revenue | $4.65B | $4.24B | $3.87B | $3.50B | $2.69B |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | – | – | – | – | – |
| SG&A | $402.93M | $335.23M | $250.42M | $231.22M | $206.66M |
| Operating Income | $1.70B | $1.57B | $1.49B | $1.37B | $1.14B |
| Interest Expense | – | – | – | – | – |
| Tax Expense | $347.22M | $352.25M | $316.59M | $250.82M | $185.35M |
| Net Income | $1.55B | $1.36B | $1.24B | $1.09B | $936.50M |
| EPS (basic) | 1.6100 | 1.4200 | 1.3000 | 4.5900 | 3.9600 |
| EPS (diluted) | 1.5900 | 1.4000 | 1.2800 | 4.5200 | 3.9000 |
| Shares (diluted) | $977.56M | $974.80M | $966.65M | $241.15M | $240.29M |